GALLI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 266
EU - Europa 128
AS - Asia 75
Totale 469
Nazione #
US - Stati Uniti d'America 266
SG - Singapore 40
IE - Irlanda 32
IT - Italia 29
CN - Cina 28
SE - Svezia 23
UA - Ucraina 14
DE - Germania 9
BE - Belgio 5
RO - Romania 3
FR - Francia 2
GB - Regno Unito 2
IN - India 2
LV - Lettonia 2
RU - Federazione Russa 2
VN - Vietnam 2
AZ - Azerbaigian 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
HU - Ungheria 1
IL - Israele 1
MK - Macedonia 1
TW - Taiwan 1
Totale 469
Città #
Chandler 68
Singapore 34
Dublin 32
Jacksonville 32
Princeton 20
Ann Arbor 15
Ashburn 15
Boardman 9
Chieti 8
Altamura 7
Nanjing 7
Los Angeles 6
Wilmington 5
Brussels 4
Dearborn 4
Washington 4
Beijing 2
Changsha 2
Dong Ket 2
Edinburgh 2
Monmouth Junction 2
Nanchang 2
Riga 2
Rome 2
Shenyang 2
Alexandria 1
Ameno 1
Andover 1
Aprilia 1
Augusta 1
Baku 1
Budapest 1
Chicago 1
Fuzhou 1
Guangzhou 1
Gura Padinii 1
Haikou 1
Hebei 1
Jiaxing 1
Lanciano 1
Leawood 1
Linfen 1
Montesilvano Marina 1
Mumbai 1
Munich 1
Norwalk 1
Paris 1
Pescara 1
Phoenix 1
Prague 1
San Mateo 1
Santa Clara 1
Shaoxing 1
Taipei 1
Tallinn 1
Tappahannock 1
Tel Aviv 1
Tianjin 1
Zhengzhou 1
Totale 322
Nome #
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 83
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting 82
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014 67
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 65
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 63
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 57
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART 49
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 40
Totale 506
Categoria #
all - tutte 2.406
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.406


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202061 0 0 0 0 0 14 15 2 13 4 11 2
2020/202143 2 1 10 2 0 10 1 1 2 2 8 4
2021/202241 1 0 1 4 1 1 1 2 2 1 8 19
2022/2023178 15 23 13 25 12 25 7 19 24 4 9 2
2023/202464 2 0 10 1 8 15 12 0 0 4 0 12
2024/202572 4 26 16 6 3 17 0 0 0 0 0 0
Totale 506